Orphan Missense Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator A Three-Step Biological Approach to Establishing a Correlation Between Genotype and Phenotype

被引:3
|
作者
Fresquet, Fleur [2 ]
Clement, Romain
Norez, Caroline
Sterlin, Adelaide
Melin, Patricia
Becq, Frederic
Kitzis, Alain [1 ,2 ]
Thoreau, Vincent
Bilan, Frederic [2 ]
机构
[1] Univ Poitiers, CNRS, UMR 6187, Inst Physiol & Cell Biol,NCSR, F-86022 Poitiers, France
[2] Univ Poitiers Hosp, CHU Poitiers, Cellular & Mol Genet Lab, Poitiers, France
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2011年 / 13卷 / 05期
关键词
NUCLEOTIDE-BINDING DOMAIN; CFTR; CHANNEL; IDENTIFICATION; TRAFFICKING; DYSFUNCTION; GENE;
D O I
10.1016/j.jmoldx.2011.05.004
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
More than 1860 mutations have been found within the human cystic fibrosis transmembrane conductance regulator (CFTR) gene sequence. These mutations can be classified according to their degree of severity in CF disease. Although the most common mutations are well characterized, few data are available for rare mutations. Thus, genetic counseling is particularly difficult when fetuses or patients with CF present these orphan variations. We describe a three-step in vitro assay that can evaluate rare missense CFTR mutation consequences to establish a correlation between genotype and phenotype. By using a green fluorescent protein-tagged CFTR construct, we expressed mutated proteins in COS-7 cells. CFTE trafficking was visualized by confocal microscopy, and the cellular localization of CFTR was determined using intracellular markers. We studied the CFTR maturation process using Western blot analysis and evaluated CFTR channel activity by automated iodide efflux assays. Of six rare mutations that we studied, five have been isolated in our laboratory. The cellular and functional impact that we observed in each case was compared with the clinical data concerning the patients in whom we encountered these mutations. In conclusion, we propose that performing this type of analysis for orphan CFTR missense mutations can improve CF genetic counseling. (J Mol Diagn 2011, 13: 520-527; DOI: 10.1016/j.jmoldx.2011.05.004)
引用
收藏
页码:520 / 527
页数:8
相关论文
共 21 条
  • [1] A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype
    Kerem, E
    NissimRafinia, M
    Argaman, Z
    Augarten, A
    Bentur, L
    Klar, A
    Yahav, Y
    Szeinberg, A
    Hiba, O
    Branski, D
    Corey, M
    Kerem, B
    PEDIATRICS, 1997, 100 (03) : E5
  • [2] Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype
    Sosnay, Patrick R.
    Raraigh, Karen S.
    Gibson, Ronald L.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2016, 63 (04) : 585 - +
  • [3] Localization Studies of Rare Missense Mutations in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Facilitate Interpretation of Genotype-Phenotype Relationships
    Krasnov, Kristina V.
    Tzetis, Maria
    Cheng, Jie
    Guggino, William B.
    Cutting, Garry R.
    HUMAN MUTATION, 2008, 29 (11) : 1364 - 1372
  • [4] Cystic fibrosis transmembrane regulator mutations and pancreatic disease: closing the gap between genotype and phenotype
    Morinville, V
    Slivka, A
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (02) : 240 - 242
  • [5] Unique Mutations of the Cystic Fibrosis Transmembrane Conductance Regulator Gene of Three Cases of Cystic Fibrosis in Nagasaki, Japan
    Izumikawa, Koichi
    Tomiyama, Yumiko
    Ishimoto, Hiroshi
    Sakamoto, Noriho
    Imamura, Yoshifumi
    Seki, Masafumi
    Sawai, Toyomitsu
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Yanagihara, Katsunori
    Mukae, Hiroshi
    Yoshimura, Kunihiko
    Kohno, Shigeru
    INTERNAL MEDICINE, 2009, 48 (15) : 1327 - 1331
  • [6] Relation between the anatomical genital phenotype and cystic fibrosis transmembrane conductance regulator gene mutations in the absence of the vas deferens
    Robert, F
    Bey-Omar, F
    Rollet, J
    Lapray, JF
    Morel, Y
    FERTILITY AND STERILITY, 2002, 77 (05) : 889 - 896
  • [7] Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator
    Vankeerberghen, A
    Wei, L
    Jaspers, M
    Cassiman, JJ
    Nilius, B
    Cuppens, H
    HUMAN MOLECULAR GENETICS, 1998, 7 (11) : 1761 - 1769
  • [8] Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): Correlation between genotype and phenotype
    Dumur, V
    Gervais, R
    Rigot, JM
    DelomelVinner, E
    Decaestecker, B
    Lafitte, JJ
    Roussel, P
    HUMAN GENETICS, 1996, 97 (01) : 7 - 10
  • [9] Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: A case report
    Levy H.
    Cannon C.L.
    Asher D.
    García C.
    Cleveland R.H.
    Pier G.B.
    Knowles M.R.
    Colin A.A.
    Journal of Medical Case Reports, 4 (1)
  • [10] Cystic fibrosis mutations lead to carboxyl-terminal fragments that highlight an early biogenesis step of the cystic fibrosis transmembrane conductance regulator
    Van Oene, M
    Lukacs, GL
    Rommens, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) : 19577 - 19584